Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity

Plasmodium vivax is the most widespread and difficult to treat cause of human malaria. The development of vaccines against the blood stages of P. vivax remains a key objective for the control and elimination of vivax malaria. Erythrocyte binding-like (EBL) protein family members such as Duffy bindin...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Han, J-H, Cho, J-S, Ong, JJY, Park, J-H, Nyunt, MH, Sutanto, E, Trimarsanto, H, Petros, B, Aseffa, A, Getachew, S, Sriprawat, K, Anstey, NM, Grigg, MJ, Barber, BE, William, T, Qi, G, Liu, Y, Pearson, RD, Auburn, S, Price, RN, Nosten, F, Rénia, L, Russell, B, Han, E-T
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Public Library of Science 2020

Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity

Míreanna comhchosúla